CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a ...

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where CG Oncology, Inc.

The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...

Trump has said that the government should raise more of its revenues from tariffs, as it did before the income tax became ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Industry makes case for PBMs ahead of ...

The Trump administration stormed into office, loudly firing workers and closing diversity programs. But behind the scenes, it ...

The bill would allow Medicare to begin negotiating with pharmaceutical companies over prices for small molecule medicines 13 ...

The University of Texas at Arlington’s Institute of Biomanufacturing and Precision Medicine and Texas A&M’s Engineering ...

Pharmacy Benefit Managers (PBMs) have evolved from relatively obscure cost-saving entities into powerful industry players ...

Rhythm Pharmaceuticals' 01/2025 presentation and Q4 2024 preliminary results press release highlight growing financial ...

Researchers at the oldest and highest-ranked food science program in the country say the food we eat is largely safe, but ...

Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...